WO1997022346A3 - Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe - Google Patents

Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe Download PDF

Info

Publication number
WO1997022346A3
WO1997022346A3 PCT/EP1996/005400 EP9605400W WO9722346A3 WO 1997022346 A3 WO1997022346 A3 WO 1997022346A3 EP 9605400 W EP9605400 W EP 9605400W WO 9722346 A3 WO9722346 A3 WO 9722346A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimycotic
antimicrobial
active substances
sugar derivatives
antiviral active
Prior art date
Application number
PCT/EP1996/005400
Other languages
English (en)
French (fr)
Other versions
WO1997022346A2 (de
Inventor
Joachim Buenger
Guenther Schneider
Joerg Schreiber
Stefan Teichmann
Florian Wolf
Original Assignee
Beiersdorf Ag
Joachim Buenger
Guenther Schneider
Joerg Schreiber
Stefan Teichmann
Florian Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag, Joachim Buenger, Guenther Schneider, Joerg Schreiber, Stefan Teichmann, Florian Wolf filed Critical Beiersdorf Ag
Priority to JP9522461A priority Critical patent/JP2000506499A/ja
Priority to EP96942332A priority patent/EP0869797A2/de
Publication of WO1997022346A2 publication Critical patent/WO1997022346A2/de
Publication of WO1997022346A3 publication Critical patent/WO1997022346A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Verwendung alkylierter und/oder acylierter Monosaccharide und/oder Oligosaccharide als antimikrobielle, antimykotische und/oder antivirale Wirkstoffe.
PCT/EP1996/005400 1995-12-16 1996-12-04 Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe WO1997022346A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP9522461A JP2000506499A (ja) 1995-12-16 1996-12-04 抗菌、抗真菌および／または抗ウイルス性活性物質としての糖誘導体の使用
EP96942332A EP0869797A2 (de) 1995-12-16 1996-12-04 Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19547160.1 1995-12-16
DE19547160A DE19547160A1 (de) 1995-12-16 1995-12-16 Verwendung von Zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale Wirkstoffe

Publications (2)

Publication Number Publication Date
WO1997022346A2 WO1997022346A2 (de) 1997-06-26
WO1997022346A3 true WO1997022346A3 (de) 1997-08-28

Family

ID=7780403

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/005400 WO1997022346A2 (de) 1995-12-16 1996-12-04 Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe

Country Status (5)

Country Link
US (1) US20020165168A1 (de)
EP (1) EP0869797A2 (de)
JP (1) JP2000506499A (de)
DE (1) DE19547160A1 (de)
WO (1) WO1997022346A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718777A1 (de) * 1997-05-03 1998-11-05 Beiersdorf Ag Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen
CA2299295C (en) * 1997-08-08 2010-11-30 Aventis Pharma Deutschland Gmbh Substituted tetrahydropyrane derivatives and method for producing same
EP0898953B1 (de) * 1997-08-29 2004-08-04 Shiseido Company, Ltd. Kosmetische Zusammensetzung für die Augenwimper
DE19749819A1 (de) * 1997-11-11 1999-05-20 Henkel Kgaa Wäßrige kosmetische Zubereitungen in Stiftform
DE19844262B4 (de) 1998-09-26 2018-12-06 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an niedermolekularen Siliconen
DE19933404A1 (de) * 1999-07-21 2001-01-25 Henkel Kgaa Reinigungsmittel für harte Oberflächen
US6664399B1 (en) 1999-09-02 2003-12-16 E. I. Du Pont De Nemours & Company Triazole linked carbohydrates
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
FR2827763B1 (fr) * 2001-07-24 2005-09-23 Cs Substance alkyloside inhibant la fixation de microorganismes, utilisation topique et composition contenant au moins une telle substance
DE10143080A1 (de) * 2001-09-03 2003-03-20 Beiersdorf Ag Insektenabwehrmittel
DE10219032A1 (de) * 2002-04-29 2003-11-06 Symrise Gmbh & Co Kg Mundhygieneprodukte
WO2004028502A1 (ja) * 2002-09-27 2004-04-08 Mochida Pharmaceutical Co., Ltd. 抗真菌剤および抗細菌剤配合洗浄用組成物
DE10330609A1 (de) 2003-07-07 2005-01-27 Beiersdorf Ag Fixierende Mehrfachgestaltung der Frisur erlaubende kosmetische Zubereitung
US20080269163A1 (en) * 2004-10-19 2008-10-30 Sostaric Joe Z Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis
DE102006011314A1 (de) 2006-03-11 2007-10-18 Peter Dr. Engels Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze
FR2899479B1 (fr) * 2006-04-10 2009-07-24 Agelys Lab Composition cicatrisante
DE102007003582A1 (de) 2007-01-24 2008-07-31 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Verwendung einer kosmetischen Zusammensetzung zur kosmetischen Behandlung der Haut
DE102009009004A1 (de) 2008-02-18 2009-09-17 Seaquist Perfect Dispensing Gmbh Abgabevorrichtung mit einem kosmetischen Fluid
FR2929509B1 (fr) * 2008-04-02 2011-01-21 Lvmh Rech L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
US7803902B2 (en) 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors
US7772181B2 (en) 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
WO2011061144A2 (en) 2009-11-20 2011-05-26 Basf Se The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen
JP2014512408A (ja) * 2011-04-29 2014-05-22 エフィック ソシエテ アノニム アルキルポリグルコシドをベースとする膣用組成物
DE102011077075A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Wirkstoffkombinationen aus Epsilon-Polylysin und einem oder mehreren Alkylglucosiden
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
FR2995782B1 (fr) * 2012-09-21 2014-10-31 Oreal Sucres anti-pelliculaires
WO2016015691A1 (en) 2014-07-30 2016-02-04 Albert SARKESSYAN A pharmaceutical composition having antibacterial and virucidal effects
CN110573141A (zh) 2017-04-28 2019-12-13 西姆莱斯有限公司 欧蓍草鲜榨植物汁浓缩物、制造和应用
US20180310566A1 (en) 2017-04-29 2018-11-01 Nevada Naturals Inc. Biofilm Penetrating Compositions and Methods
MX2020002347A (es) 2017-08-31 2020-10-28 Basf Se Uso de principios activos refrescantes fisiologicos y agentes que contienen dichos principios activos.
WO2022008163A1 (en) * 2020-07-10 2022-01-13 Unilever Ip Holdings B.V. Use of trehalose as prebiotic for inhibiting ailment inducing microorganisms

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144894A2 (de) * 1983-12-07 1985-06-19 Bayer Ag Pharmazeutische Verwendung von substituierten O-Acyl-glycosiden
US4898934A (en) * 1987-09-05 1990-02-06 Huels Aktiengesellschaft Process for manufacturing light-colored alkyloligogycosides and alkylglycosides
JPH02306906A (ja) * 1989-05-19 1990-12-20 Kurita Water Ind Ltd 抗微生物剤
JPH04266827A (ja) * 1991-02-20 1992-09-22 Sanyo Chem Ind Ltd 抗菌剤
WO1993002657A1 (fr) * 1991-08-07 1993-02-18 L'oreal Utilisation d'alkylpolyglycosides et/ou de derives o-acyles du glucose pour le traitement de la chute des cheveux
JPH05139980A (ja) * 1991-11-22 1993-06-08 Dainippon Ink & Chem Inc 持続性抗ウイルス液剤
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
WO1996023479A2 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive wirkstoffe

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN141230B (de) * 1973-12-14 1977-02-05 Strategic Medical Res Corp
AU1227276A (en) * 1975-03-28 1977-09-29 Strategic Medical Res Corp Ethers of monosaccarides
CH630255A5 (en) * 1977-11-03 1982-06-15 Muehlemann Hans R Agent for dental and gingival hygiene
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation
US4518517A (en) * 1983-03-16 1985-05-21 Colgate-Palmolive Company Non-antimicrobial deodorant cleansing composition
DE3316250A1 (de) * 1983-05-04 1984-11-08 Henkel KGaA, 4000 Düsseldorf Verwendung fuer n-alkylierten 1-amino-1-desoxy-d-fructopyranosen und sie enthaltender zusammensetzungen als antimikrobiell wirksame mittel
US4668422A (en) * 1985-05-31 1987-05-26 A. E. Staley Manufacturing Company Liquid hand-soap or bubble bath composition
ATE78166T1 (de) * 1985-10-22 1992-08-15 Silvetti Anthony N Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
JPH01299233A (ja) * 1988-05-27 1989-12-04 Dai Ichi Kogyo Seiyaku Co Ltd 皮膚創傷治療剤
JPH01311014A (ja) * 1988-06-06 1989-12-15 Taiyo Kagaku Co Ltd 抗菌性皮膚外用剤
JPH03145425A (ja) * 1989-10-30 1991-06-20 Dainippon Ink & Chem Inc 抗ウィルス剤
CA2071915A1 (en) * 1990-08-23 1992-02-24 Tadao Shoji Antiviral agent
DE4110333A1 (de) * 1991-03-28 1991-09-19 Siemens Ag Verfahren und einrichtung zur katalytischen reduktion
US5330674A (en) * 1992-09-09 1994-07-19 Henkel Corporation Method for increasing the efficiency of a disinfectant cleaning composition using alkyl polyglycosides
DE4230504A1 (de) * 1992-09-15 1994-03-17 Beiersdorf Ag Stabile kosmetische Mittel
DE4410778C2 (de) * 1994-03-28 2002-09-12 Beisel Guenther Mittel zur Herstellung eines medizinisch und/oder kosmetisch und/oder keimabtötend und/oder parasitenabtötend wirkenden wässrigen stabilen Schaums und dessen Verwendung

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144894A2 (de) * 1983-12-07 1985-06-19 Bayer Ag Pharmazeutische Verwendung von substituierten O-Acyl-glycosiden
US4898934A (en) * 1987-09-05 1990-02-06 Huels Aktiengesellschaft Process for manufacturing light-colored alkyloligogycosides and alkylglycosides
JPH02306906A (ja) * 1989-05-19 1990-12-20 Kurita Water Ind Ltd 抗微生物剤
JPH04266827A (ja) * 1991-02-20 1992-09-22 Sanyo Chem Ind Ltd 抗菌剤
WO1993002657A1 (fr) * 1991-08-07 1993-02-18 L'oreal Utilisation d'alkylpolyglycosides et/ou de derives o-acyles du glucose pour le traitement de la chute des cheveux
JPH05139980A (ja) * 1991-11-22 1993-06-08 Dainippon Ink & Chem Inc 持続性抗ウイルス液剤
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
WO1996023479A2 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive wirkstoffe

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9106, Derwent World Patents Index; Class D22, AN 91-040092, XP002029142 *
DATABASE WPI Section Ch Week 9244, Derwent World Patents Index; Class B04, AN 92-363075, XP002029143 *
DATABASE WPI Section Ch Week 9327, Derwent World Patents Index; Class B04, AN 93-216664, XP002034390 *
FRANCIS A. HUGHES ET AL.: "Physical and functional properties of some higher alkyl polyglucosides", J. AM. OIL CHEM. SOC., vol. 47, 1970, pages 162 - 167, XP000652777 *
SHUICHI MATSUMURA ET AL.: "Surface activities, biodegradability and antimicrobial properties of n-alkyl glucosides, mannosides and galactosides", J. AM. OIL CHEM. SOC., vol. 67, no. 12, 1990, pages 996 - 1001, XP000652676 *
SHUICHI MATSUMURA ET AL.: "Surface activities, foam suppression, biodegradability and antimicrobial properties of s-alkyl glucopyranosides", YUKAGAKU, vol. 40, no. 9, 1991, pages 709 - 714, XP000653016 *
TETSURO IKEKAWA ET AL.: "Studies on synthesis of 3-O-alkyl-D-glucose and 3-O-alkyl-D-allose derivatives and their biological activities", CHEM. PHARM. BULL., vol. 35, no. 7, 1987, pages 2894 - 2899, XP000652680 *
Y.SHOYAMA ET AL.: "Four caffeoyl glycosides from callus tissue of Rehmannia Glutinosa", PHYTOCHEMISTRY, vol. 25, no. 7, 1986, pages 1633 - 1636, XP000652010 *

Also Published As

Publication number Publication date
JP2000506499A (ja) 2000-05-30
EP0869797A2 (de) 1998-10-14
US20020165168A1 (en) 2002-11-07
WO1997022346A2 (de) 1997-06-26
DE19547160A1 (de) 1997-06-19

Similar Documents

Publication Publication Date Title
WO1997022346A3 (de) Verwendung von zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale wirkstoffe
WO1996023479A3 (de) Antiadhäsive wirkstoffe
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU6928596A (en) Heterocyclically substituted biphenylamide derivatives, their preparation and their use as fungicides
CA2213719A1 (en) Transparent rapid-release preparation of non-steroid analgesics
AU5603894A (en) Pluripotential quiescent stem cell population
AU5275596A (en) 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives having PDEIV and cytokine activity
AU7705694A (en) Substituted urea and isothiourea derivatives as no synthase inhibitors
AU4930299A (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
AU7295196A (en) 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU6378094A (en) Heterocycle-containing amidine derivatives, their preparation and use
AU7295096A (en) 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU1319592A (en) Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients
AU6658596A (en) Substituted 1-phenyluracil derivatives, their preparation and their use as herbicides
AU8078391A (en) Alkylated oligosaccharides and acetyl derivatives of the same
AU703235B2 (en) 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity
EP0745608A3 (de) Neuartige Glukose- und Sophoroselipide, ein Verfahren zu deren Herstellung un deren Verwendung
AU7193494A (en) Saccharides, their synthesis and use
AU5834498A (en) Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts
AU695666B2 (en) N-acylpiperazine derivative, antibacterial drug, and anti- ulcer drug
AU2651297A (en) Indolyl-substituted uracil derivatives and herbicides comprising them as active ingredients
AU6391994A (en) Compounds active against aids and related infections
AU5998696A (en) Fungicidal active agent combinations
AU5260096A (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996942332

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 522461

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996942332

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09091602

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1996942332

Country of ref document: EP